The global nicotine gum market size is estimated to grow by $1.34 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 5.71% during the forecast period. An increasing number of people trying to quit smoking is driving market growth, with a trend toward growing new product launches related to nicotine. However, health issues associated with smoking cessation products pose a challenge. Key market players include Alchem International Pvt. Ltd., Alkalon AS, British American Tobacco Plc, Cambrex Corp., Cipla Inc., Dr Reddys Laboratories Ltd., Enorama Pharma AB, Fertin Pharma AS, GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., ITC Ltd., Johnson and Johnson Services Inc., Leeford Healthcare Ltd., Lil Drug Store Products Inc., Lucy Goods Inc., Major Pharmaceuticals Inc., Perrigo Co. Plc, Rogue Holdings LLC, Trumac Healthcare, and Walgreens Boots Alliance Inc.
New product launches, such as Perrigo Company plc’s latest 2 mg and 4 mg nicotine-coated mint lozenges, are essential for market growth in the nicotine gum industry. These lozenges, approved by the US Food and Drug Administration for over-the-counter sale, will be available under retailer’s store brands and are anticipated to generate significant revenue. The market potential is substantial, with sales of approximately USD20 million for the equivalent national brand product in the previous year. These new offerings will help companies increase market share and cater to consumers seeking smoking cessation solutions.
Nicotine gum is a popular nicotine replacement therapy (NRT) product used by individuals looking to quit tobacco consumption. The global nicotine gum market is witnessing significant growth due to increasing health awareness and rising concerns over the harmful effects of tobacco smoke on lung cancer, cardiac diseases, and respiratory disorders. Nicorette, a leading brand of nicotine gum, dominates the market with long-lasting gums in 2mg and 4mg strengths. Healthcare professionals recommend NRTs like nicotine gum as practical tools for managing nicotine cravings during smoking cessation programs. New flavors and convenient delivery systems are trending to attract health-conscious consumers, including light smokers. Pharmacies, online stores, and rehab centers stock a range of NRTs, including tablets, powders, and chewing gums. Nicotine patches are also popular smoking cessation aids. Changing consumer preferences and smoking cessation awareness campaigns are driving market growth. However, the market faces competition from other NRTs and cigarette promotion, highlighting the need for effective health education and smoking cessation programs.
Market Challenges
The nicotine gum market may experience hindrances due to growing awareness regarding the potential health risks associated with smoking cessation products. Long-term usage of nicotine gums can lead to various health issues, including hair loss, skin irritation, elevated blood pressure, irregular heartbeat, insulin resistance, gastrointestinal problems, nausea, and dental problems such as teeth and jaw issues from continuous chewing. Additionally, nicotine patches have side effects like skin irritation, itching, dizziness, and headache. Furthermore, research indicates that e-cigarettes, which are alternative smoking cessation methods, contain harmful ingredients like propylene glycol and vegetable glycerin and produce toxic chemicals such as acetaldehyde, acrolein, and formaldehyde, which can lead to lung and cardiovascular diseases. The health risks associated with these products may deter consumers and hinder the growth of the global nicotine gum market during the forecast period.
The Nicotine Gum market faces several challenges in the current scenario. Traditional flavors are no longer sufficient for consumers, leading to the need for new and innovative flavors. Convenient delivery systems are in high demand, with chewing gums, tablets, powders, lozenges, dissolvable films, and tiny nicotine pouches gaining popularity. Smoking cessation programs are essential, with the 2mg and 4mg segments being the most popular among smokers and light smokers. Pharmacies, rehab centers, health organizations, online stores, and smoking cessation aids are vital players. However, health risks associated with nicotine gums, such as heart conditions and respiratory problems, remain a concern. Tobacco use promotion and cigarette advertising continue to pose challenges. Health awareness campaigns and personalized nicotine gum offerings are crucial to attract health-conscious consumers. The market is evolving, focusing on heart disease prevention, changing consumer preferences, and smoking cessation awareness. Nicotine patches and other smoking cessation aids are also significant competitors.
